Sexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas.
ACTH-secreting adenomas
Cushing’s disease
gender
gene expression profiling
neuroendocrine tumours
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Mar 2020
13 Mar 2020
Historique:
received:
04
02
2020
revised:
09
03
2020
accepted:
10
03
2020
entrez:
19
3
2020
pubmed:
19
3
2020
medline:
19
3
2020
Statut:
epublish
Résumé
(1) Background. Cushing's disease presents gender disparities in prevalence and clinical course. Little is known, however, about sexual dimorphism at the level of the corticotrope adenoma itself. The aim of the present study was to evaluate molecular features of ACTH-secreting pituitary adenomas collected from female and male patients with Cushing's disease. (2) Methods. We analyzed 153 ACTH-secreting adenomas collected from 31 men and 122 women. Adenomas were established in culture and ACTH synthesis and secretion assessed in basal conditions as well as during incubation with CRH or dexamethasone. Concurrently, microarray analysis was performed on formalin-fixed specimens and differences in the expression profiles between specimens from male and female patients identified. (3) Results. ACTH medium concentrations in adenomas obtained from male patients were significantly lower than those observed in adenomas from female patients. This could be observed for baseline as well as modulated secretion. Analysis of corticotrope transcriptomes revealed considerable similarities with few, selected differences in functional annotations. Differentially expressed genes comprised genes with known sexual dimorphism, genes involved in tumour development and genes relevant to pituitary pathophysiology. (4) Conclusions. Our study shows for the first time that human corticotrope adenomas present sexual dimorphism and underlines the need for a gender-dependent analysis of these tumours. Differentially expressed genes may represent the basis for gender-tailored target therapy.
Identifiants
pubmed: 32183012
pii: cancers12030669
doi: 10.3390/cancers12030669
pmc: PMC7139870
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Clin Biochem. 2000 Nov;37 ( Pt 6):770-4
pubmed: 11085621
Ecancermedicalscience. 2013 Dec 18;7:381
pubmed: 24386010
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Neurol India. 2019 May-Jun;67(3):698-705
pubmed: 31347538
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
J Cell Mol Med. 2019 Aug;23(8):5751-5761
pubmed: 31222932
Am J Clin Exp Urol. 2018 Apr 01;6(2):62-77
pubmed: 29666834
Sci Rep. 2016 Jan 12;6:19119
pubmed: 26755347
Neuroendocrinology. 2004 Mar;79(3):119-24
pubmed: 15103224
Anat Histol Embryol. 2008 Aug;37(4):263-71
pubmed: 18215204
J Psychopharmacol. 2002 Dec;16(4):283-9
pubmed: 12503826
Biomed Mater Eng. 2014;24(6):3439-46
pubmed: 25227055
J Clin Endocrinol Metab. 2003 Apr;88(4):1554-8
pubmed: 12679438
Environ Health Perspect. 2016 Aug;124(8):1199-207
pubmed: 26955063
J Immunol Res. 2014;2014:814598
pubmed: 24741625
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
Am J Pathol. 1983 Nov;113(2):198-206
pubmed: 6638150
Cancer Cell. 2016 May 9;29(5):711-722
pubmed: 27165743
J Neuroendocrinol. 2011 Dec;23(12):1214-21
pubmed: 21883533
Neurosurg Focus. 2007;23(3):E7
pubmed: 17961019
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
J Clin Endocrinol Metab. 2004 Aug;89(8):3818-20
pubmed: 15292311
J Clin Endocrinol Metab. 2015 Jul;100(7):E997-1004
pubmed: 25942478
Biomark Med. 2019 Sep;13(13):1107-1117
pubmed: 31468986
Eur J Endocrinol. 2014 Feb 04;170(3):393-400
pubmed: 24362410
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
Semin Cell Dev Biol. 2020 Feb;98:15-25
pubmed: 31085323
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):213-22
pubmed: 27364396
Exp Clin Endocrinol Diabetes. 2011 Apr;119(4):221-4
pubmed: 21374543
Endocrine. 2019 Feb;63(2):240-246
pubmed: 30315484
Horm Res. 2009 Jan;71 Suppl 1:123-7
pubmed: 19153521
Anticancer Res. 2010 Jul;30(7):2897-904
pubmed: 20683030
Curr Drug Metab. 2017;18(12):1095-1105
pubmed: 28558634
Reprod Biol Endocrinol. 2018 Feb 17;16(1):14
pubmed: 29454353
Int J Oncol. 2017 Nov;51(5):1357-1369
pubmed: 29048660
J Urol. 2001 Sep;166(3):1078-82
pubmed: 11490302
Neuropeptides. 1994 Nov;27(5):297-303
pubmed: 7862261
Ann Endocrinol (Paris). 2001 Apr;62(2):168-72
pubmed: 11353889
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31
pubmed: 26222757
J Clin Endocrinol Metab. 2009 Apr;94(4):1118-24
pubmed: 19141584
J Clin Endocrinol Metab. 2014 May;99(5):1623-30
pubmed: 24471573
J Neuroendocrinol. 2018 Sep;30(9):e12628
pubmed: 29920815
Tumour Biol. 1995;16(6):353-64
pubmed: 7569682
Nat Commun. 2015 Feb 09;6:6289
pubmed: 25662504
J Endocrinol. 2016 Nov;231(2):135-145
pubmed: 27587848
J Clin Invest. 2011 Dec;121(12):4712-21
pubmed: 22105169
BMC Genomics. 2009 Mar 15;10:109
pubmed: 19284880
Oncologist. 2007 Oct;12(10):1225-36
pubmed: 17962616
Endocrine. 2015 Dec;50(3):580-9
pubmed: 26160393
Endocr Pathol. 2008 Spring;19(1):27-33
pubmed: 18228161
J Bioinform Comput Biol. 2012 Dec;10(6):1231003
pubmed: 23075208
Int J Mol Sci. 2016 Sep 29;17(10):
pubmed: 27690016
Endocrinology. 2014 Sep;155(9):3538-49
pubmed: 24926820
Nat Rev Cancer. 2016 May;16(5):330-9
pubmed: 27079803
Vitam Horm. 2019;111:1-16
pubmed: 31421696
Semin Cancer Biol. 2020 Dec;67(Pt 1):57-64
pubmed: 31445218
Obes Res. 1994 Sep;2(5):486-508
pubmed: 16353601
J Endocrinol. 2000 May;165(2):493-501
pubmed: 10810313
Biomed Environ Sci. 2018 Dec;31(12):927-932
pubmed: 30636667
Biomarkers. 2013 Aug;18(5):436-45
pubmed: 23829492
Pituitary. 2014 Oct;17(5):464-9
pubmed: 24085685
J Endocrinol. 2003 Jun;177(3):373-9
pubmed: 12773117
Clin Endocrinol (Oxf). 1990 Jan;32(1):127-34
pubmed: 2158868
Horm Metab Res. 2008 Aug;40(8):524-7
pubmed: 18398784
J Natl Cancer Inst Monogr. 2000;(27):67-73
pubmed: 10963620
Pancreas. 2014 Oct;43(7):996-1002
pubmed: 25058880
Rev Endocr Metab Disord. 2012 Sep;13(3):151-61
pubmed: 21607612
Mol Endocrinol. 1988 Jul;2(7):633-40
pubmed: 3412328
Cancer Cell. 2020 Jan 13;37(1):123-134.e5
pubmed: 31883967
Front Endocrinol (Lausanne). 2016 Oct 26;7:140
pubmed: 27833586
J Clin Endocrinol Metab. 1999 Apr;84(4):1351-6
pubmed: 10199778
Future Oncol. 2010 Nov;6(11):1771-9
pubmed: 21142662
Neurol Res. 2005 Apr;27(3):324-32
pubmed: 15845217
Trends Cancer. 2016 Jul;2(7):325-326
pubmed: 28741533
Front Horm Res. 2006;35:32-49
pubmed: 16809921
Neuroendocrinology. 2020;110(1-2):119-129
pubmed: 31280266
Front Genet. 2012 Nov 28;3:268
pubmed: 23226157
Endocrine. 2017 Mar;55(3):853-860
pubmed: 27220856
J Clin Endocrinol Metab. 2011 Aug;96(8):E1237-45
pubmed: 21632819
Eur J Endocrinol. 2020 Feb;182(2):207-217
pubmed: 31804965
Int J Endocrinol. 2015;2015:949620
pubmed: 26064114
Chin Med J (Engl). 2014;127(22):3948-56
pubmed: 25421196
Cancer Sci. 2019 Apr;110(4):1208-1219
pubmed: 30719818
J Endocrinol. 2001 Apr;169(1):87-96
pubmed: 11250650
Postepy Hig Med Dosw (Online). 2016 Nov 7;70(0):1117-1123
pubmed: 27892895
Mol Endocrinol. 2012 Jun;26(6):1014-27
pubmed: 22543271
Cancer Res. 2018 Oct 1;78(19):5504-5505
pubmed: 30275051
J Clin Endocrinol Metab. 2004 Dec;89(12):6348-57
pubmed: 15579802
J Endocr Soc. 2017 Jan 20;1(2):127-143
pubmed: 29264472
J Neurooncol. 2014 Feb;116(3):523-31
pubmed: 24407733
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2535-2546
pubmed: 30844069
Eur J Endocrinol. 2019 Dec;181(6):615-627
pubmed: 31581124
Neuro Oncol. 2019 Oct 9;21(10):1273-1283
pubmed: 31222332
Arch Histol Cytol. 1990 Dec;53(5):585-91
pubmed: 2078403
Clin Endocrinol (Oxf). 2015 Jul;83(1):72-7
pubmed: 25388128
Brain Res. 2015 May 22;1608:14-20
pubmed: 25765155
Front Neuroendocrinol. 2005 Oct-Dec;26(3-4):109-30
pubmed: 16289311
Front Pharmacol. 2018 Dec 06;9:1345
pubmed: 30574087
J Clin Endocrinol Metab. 2008 Dec;93(12):4624-32
pubmed: 18796519
Clin Endocrinol (Oxf). 2014 Mar;80(3):403-10
pubmed: 23889360
Mol Cell Endocrinol. 2014 Jan 25;382(1):652-664
pubmed: 23810978